Obesity

The correlation of apolipoprotein B and apolipoprotein A1 with metabolic dysfunction‐associated steatotic liver disease in children and adolescents with obesity

Pediatr ObesPublished Retrospective cross-sectional study

Authors' conclusion

Elevated levels of apoB and the apoB/apoA1 ratio have been strongly connected to increased MASLD prevalence in children and adolescents with obesity; hence, signifying their potential usefulness as biomarkers for early detection and intervention.

Study context

Population
Children and adolescents with obesity at a children's hospital, 2020–2022313 with MASLD
Participants
916 children
Exposure
Apolipoprotein B (apoB), apolipoprotein A1 (apoA1) and apoB/apoA1 ratio percentiles vs 50th percentile
Outcome
Presence of MASLD (US)
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

MASLD

Odds (fold higher)

4.83

95% CI 2.02–11.56

apoB 95th percentile

Fold higher prevalence

2.41

95% CI 1.33–4.37

apoB/apoA1 95th percentile

Observational data: associations, not effects.

Original publication

The correlation of apolipoprotein B and apolipoprotein A1 with metabolic dysfunction‐associated steatotic liver disease in children and adolescents with obesity. Pediatr Obes. Published 6 May 2025. doi:10.1111/ijpo.70017

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.